Human leucocyte antigen class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity

Clinical and Experimental Immunology

Volumn 152, Issue 1, 2008, Pages 95-101

  Boyton, R J ^a,b,e   Smith, J ^c   Jones, M ^d   Reynolds, C ^a   Ozerovitch, L ^b   Chaudhry, A ^a   Wilson, R ^b   Rose, M ^c   Altmann, D M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c HAREFIELD HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Adaptive immunity; Bronchiectasis; HLA; Human; Infection

Indexed keywords

GENOMIC DNA; HLA A ANTIGEN; HLA A2 ANTIGEN; HLA B ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR6 ANTIGEN;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; BRONCHIECTASIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; HAPLOTYPE; HLA SYSTEM; HUMAN; IMMUNOGENETICS; LUNG INFECTION; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; BRONCHIECTASIS; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DQ ANTIGENS; HLA-DR1 ANTIGEN; HUMANS; MALE; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS;

EID: 40449086705     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03596.x     Document Type: Article

References (31)

1. Wilson R, Boyton RJ. Bronchiectasis. In : Laurent GJ, Shapiro SD, eds. Encyclopedia of respiratory medicine, Vol. 1. Oxford, UK : Elsevier, 2006 : 259 68.
2. Cohen M, Sahn SA. Bronchiectasis in systemic disease. Chest 1999 116 : 1063.
3. Pasteur MC, Pasteur MC, Helliwell SM et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000 162 : 1277.
4. Boyton RJ, Smith J, Ward R et al. HLA-C and killer cell immunoglobulin-like receptor (KIR) genes in susceptibility to bronchiectasis. Am J Respir Crit Care Med 2006 173 : 327.
5. Boyton RJ, Altmann DM. Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol 2007 149 : 1 8.
6. Gadola SD, Moins-Teisserenc HT, Trowsdale J et al. TAP deficiency syndrome. Clin Exp Immunol 2000 121 : 173.
7. Nelson GW, Martin MP, Gladman D et al. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 2004 173 : 4273.
8. Rajagopalan S, Long EO. Understanding how combinations of HLA and KIR genes influence disease. J Exp Med 2005 201 : 1025 9.
9. Bashirova A, Martin M, McVicar D et al. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet 2006 7 : 277 300.
10. + T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax 1998 53 : 685.
11. Silva JR, Jones JA, Cole PJ et al. The immunological component of the cellular inflammatory infiltrate in bronchiectasis. Thorax 1989 44 : 668.
12. Angrill J, Agusti C, Celis RD et al. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am J Respir Crit Care Med 2001 164 : 1628.
13. Frodsham AJ, Hill AV. Genetics of infectious diseases. Hum Mol Genet 2004 13 : R187 9.
14. Martin MP, Qi Y, Gao X et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 2007 39 : 733.
15. Alter G, Teigen N, Ahern R et al. Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J Infect Dis 2007 195 : 1452.
16. Park MH, Kim YW, Yoon HI et al. Association of HLA class I antigens with diffuse panbronchiolitis in Korean patients. Am J Respir Crit Care Med 1999 159 : 526 9.
17. Aron Y, Polla BS, Bienvenu T et al. HLA class II polymorphism in cystic fibrosis. A possible modifier of pulmonary phenotype. Am J Respir Crit Care Med 1999 159 : 1464 8.
18. Kubo K, Yamazaki Y, Hanaoka M et al. Analysis of HLA antigens in Mycobacterium avium-intracellulare pulmonary infection. Am J Respir Crit Care Med 2000 161 : 1368 71.
19. Altmann DM. HLA-DQ associations with autoimmune disease. Autoimmunity 1992 14 : 79.
20. Spurkland A, Celius EG, Knutsen I et al. The HLA-DQ(alpha 1*0102, beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR (alpha 1*01, beta 1*1501) heterodimer. Tissue Antigens 1997 50 : 15 22.
21. Smith SM, Brookes R, Klein MR et al. Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A. J Immunol 2000 165 : 7088 95.
22. Parham P, Arnett KL, Adams EJ et al. Episodic evolution and turnover of HLA-B in the indigenous human populations of the Americas. Tissue Antigens 1997 50 : 219 32.
23. Arber N, Klein T, Meiner Z et al. Close association of HLA-B51 and B52 in Israeli patients with Behcet's syndrome. Ann Rheum Dis 1991 50 : 351 3.
24. Falk K, Rotzschke O, Takiguchi M et al. Peptide motifs of HLA-B51-B52 and -B78 molecules, and implications for Behcet's disease. Int Immunol 1995 7 : 223 8.
25. Boyton RJ, Reynolds C, Wahid FN et al. IFNgamma and CXCR-1 gene polymorphisms in idiopathic bronchiectasis. Tissue Antigens 2006 68 : 325 30.
26. Hasan A, Fortune F, Wilson A et al. Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. Lancet 1996 347 : 789 94.
27. Altmann DM, Sansom D, Marsh SGE. What is the basis for HLA-DQ associations with autoimmune disease. Immunol Today 1991 12 : 267.
28. Serjeantson SW, Gao X, Hawkins BR et al. Novel HLA-DR-2-related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosis. Eur J Immunogenet 1992 19 : 11 9.
29. Anderson RP, Degano P, Godkin AJ et al. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000 6 : 337 42.
30. Vankayalapati R, Klucar P, Wizel B et al. NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen. J Immunol 2004 172 : 130.
31. Hussell T, Openshaw P. IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions. J Immunol 2000 165 : 7109 15.